Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated MSC Injections in Progressive MS
NCT04823000Phase 2Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Jan 2013
- Primary completion
- Dec 2016
- Modality
- Stem Cell Therapies, Adoptive Cell Transfer
01
Overview
A Phase 2 trial of MSC-NG01 in multiple sclerosis (MS), sponsored by Hadassah Medical Organization. Started Jan 2013; status: completed.
02
Drugs
MSC-NG01
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04823000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04823000.